MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $33,000 | -78.8% | 54,445 | -6.7% | 0.00% | – |
| Q4 2021 | $156,000 | -3.1% | 58,383 | 0.0% | 0.00% | – |
| Q3 2021 | $161,000 | -62.2% | 58,383 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $426,000 | -25.1% | 149,520 | -9.9% | 0.00% | 0.0% |
| Q1 2021 | $569,000 | +29.9% | 165,876 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $438,000 | -9.5% | 165,876 | +7.0% | 0.00% | 0.0% |
| Q3 2020 | $484,000 | -23.9% | 155,004 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $636,000 | +156.5% | 154,003 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $248,000 | -4.6% | 154,003 | +46.8% | 0.00% | – |
| Q4 2019 | $260,000 | +47.7% | 104,924 | 0.0% | 0.00% | – |
| Q3 2019 | $176,000 | -32.8% | 104,924 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $262,000 | +7.8% | 104,924 | +380.4% | 0.00% | 0.0% |
| Q1 2014 | $243,000 | +38.9% | 21,841 | 0.0% | 0.00% | – |
| Q4 2013 | $175,000 | -9.8% | 21,841 | +27.4% | 0.00% | -100.0% |
| Q3 2013 | $194,000 | +63.0% | 17,141 | +2.4% | 0.00% | – |
| Q2 2013 | $119,000 | – | 16,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,459,124 | $9,132,000 | 11.08% |
| Sio Capital Management, LLC | 2,373,841 | $6,267,000 | 2.28% |
| Vivo Capital, LLC | 5,778,106 | $15,254,000 | 1.95% |
| BVF INC/IL | 2,978,708 | $7,864,000 | 1.03% |
| Boxer Capital, LLC | 2,913,091 | $7,691,000 | 0.95% |
| NEA Management Company, LLC | 5,720,572 | $15,102,000 | 0.60% |
| Perceptive Advisors | 4,400,440 | $11,617,000 | 0.44% |
| INDUS CAPITAL PARTNERS, LLC | 631,513 | $1,667,000 | 0.30% |
| BAILARD, INC. | 381,292 | $1,007,000 | 0.07% |
| KNOTT DAVID M | 38,590 | $102,000 | 0.05% |